BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15347996)

  • 1. Estrogenic activity of chemicals for dental and similar use in vitro.
    Hashimoto Y; Moriguchi Y; Oshima H; Nishikawa J; Nishihara T; Nakamura M
    J Mater Sci Mater Med; 2000 Aug; 11(8):465-8. PubMed ID: 15347996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic activity of phthalate esters by in vitro VTG assay using primary-cultured Xenopus hepatocytes.
    Nomura Y; Mitsui N; Bhawal UK; Sawajiri M; Tooi O; Takahashi T; Okazaki M
    Dent Mater J; 2006 Sep; 25(3):533-7. PubMed ID: 17076324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic activity of tissue conditioners in vitro.
    Hashimoto Y; Kawaguchi M; Miyazaki K; Nakamura M
    Dent Mater; 2003 Jun; 19(4):341-6. PubMed ID: 12686300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogenic activity of dental materials and bisphenol-A related chemicals in vitro.
    Hashimoto Y; Nakamura M
    Dent Mater J; 2000 Sep; 19(3):245-62. PubMed ID: 11218845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k.
    Hong EJ; Ji YK; Choi KC; Manabe N; Jeung EB
    J Reprod Dev; 2005 Apr; 51(2):253-63. PubMed ID: 15883486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogenic activity of phthalate esters in vitro.
    Harris CA; Henttu P; Parker MG; Sumpter JP
    Environ Health Perspect; 1997 Aug; 105(8):802-11. PubMed ID: 9347895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro screening system for estrogenicity: comparison of stably transfected human estrogen receptor-α transcriptional activation (OECD TG455) assay and estrogen receptor (ER) binding assay.
    Lee HK; Kim TS; Kim CY; Kang IH; Kim MG; Jung KK; Kim HS; Han SY; Yoon HJ; Rhee GS
    J Toxicol Sci; 2012; 37(2):431-7. PubMed ID: 22467034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower concentrations of phthalates induce proliferation in human breast cancer cells.
    Chen FP; Chien MH
    Climacteric; 2014 Aug; 17(4):377-84. PubMed ID: 24228746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
    Zacharewski TR; Meek MD; Clemons JH; Wu ZF; Fielden MR; Matthews JB
    Toxicol Sci; 1998 Dec; 46(2):282-93. PubMed ID: 10048131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro estrogenic activity of representative endocrine disrupting chemicals mixtures at environmentally relevant concentrations.
    Yu H; Caldwell DJ; Suri RP
    Chemosphere; 2019 Jan; 215():396-403. PubMed ID: 30336316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro.
    Okubo T; Suzuki T; Yokoyama Y; Kano K; Kano I
    Biol Pharm Bull; 2003 Aug; 26(8):1219-24. PubMed ID: 12913283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions.
    Ghisari M; Bonefeld-Jorgensen EC
    Toxicol Lett; 2009 Aug; 189(1):67-77. PubMed ID: 19463926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based system.
    Ho PW; Tse ZH; Liu HF; Lu S; Ho JW; Kung MH; Ramsden DB; Ho SL
    PLoS One; 2013; 8(9):e74065. PubMed ID: 24040167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of estrogenic potential of di-n-butyl phthalate and butyl benzyl phthalate in vivo.
    Ahmad R; Verma Y; Gautam AK; Kumar S
    Toxicol Ind Health; 2015 Dec; 31(12):1296-303. PubMed ID: 23833243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogenic activity, chemical levels and health risk assessment of municipal distribution point water from Pretoria and Cape Town, South Africa.
    Van Zijl MC; Aneck-Hahn NH; Swart P; Hayward S; Genthe B; De Jager C
    Chemosphere; 2017 Nov; 186():305-313. PubMed ID: 28787686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s).
    Picard K; Lhuguenot JC; Lavier-Canivenc MC; Chagnon MC
    Toxicol Appl Pharmacol; 2001 Apr; 172(2):108-18. PubMed ID: 11298497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of estrogenic compounds in paperboard for dry food packaging with the ERE-CALUX bioassay.
    Vandermarken T; Boonen I; Gryspeirt C; Croes K; Van Den Houwe K; Denison MS; Gao Y; Van Hoeck E; Elskens M
    Chemosphere; 2019 Apr; 221():99-106. PubMed ID: 30634153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Demonstration of the Uncertainty in Predicting the Estrogenic Activity of Individual Chemicals and Mixtures From an In Vitro Estrogen Receptor Transcriptional Activation Assay (T47D-KBluc) to the In Vivo Uterotrophic Assay Using Oral Exposure.
    Conley JM; Hannas BR; Furr JR; Wilson VS; Gray LE
    Toxicol Sci; 2016 Oct; 153(2):382-95. PubMed ID: 27473340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food-associated estrogenic compounds induce estrogen receptor-mediated luciferase gene expression in transgenic male mice.
    Ter Veld MG; Zawadzka E; van den Berg JH; van der Saag PT; Rietjens IM; Murk AJ
    Chem Biol Interact; 2008 Jul; 174(2):126-33. PubMed ID: 18501883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro hormone activities of selected phthalates using reporter gene assays.
    Shen O; Du G; Sun H; Wu W; Jiang Y; Song L; Wang X
    Toxicol Lett; 2009 Dec; 191(1):9-14. PubMed ID: 19643168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.